IBD vs VNM (2019)
KEY RATIOS
ROE (%)
IBD
8.02
VNM
35.5
ROA (%)
IBD
7.14
VNM
23.61
Gross Margin (%)
IBD
17.33
VNM
47.11
Net Margin (%)
IBD
6.56
VNM
18.71
Debt/Equity
IBD
0.12
VNM
0.5
Equity Multiplier
IBD
1.12
VNM
1.5
Balance Sheet
| Item | IBD | VNM |
|---|---|---|
| Current Assets | 101.5 | 24,722 |
| Non-Current Assets | 8.2 | 19,978 |
| Fixed Assets | 7.5 | 14,894 |
| Total Assets | 109.7 | 44,700 |
| Total Liabilities | 12.0 | 14,969 |
| Current Liabilities | 12.0 | 14,443 |
| Owner's Equity | 97.7 | 29,731 |
| Non-Current Liabilities | — | 525.8 |
Income Statement
| Item | IBD | VNM |
|---|---|---|
| Revenue | 119.5 | 56,400 |
| Profit Attr. to Parent | 7.8 | 10,581 |
| Cost of Goods Sold | -98.1 | -29,746 |
| Gross Profit | 20.7 | 26,572 |
| Selling Expenses | -4.1 | -12,993 |
| G&A Expenses | -9.4 | -1,396.3 |
| Operating Profit | 9.8 | 12,797 |
| Profit Before Tax | 9.8 | 12,796 |
| Net Profit After Tax | 7.8 | 10,554 |
Cash Flow
| Item | IBD | VNM |
|---|---|---|
| Depreciation | 1.9 | 1,948.1 |
| Tax Paid | -0.97 | -2,033.6 |
| Operating Cash Flow | 18.6 | 11,410 |
| Capex | -0.15 | -2,158.2 |
| Investing Cash Flow | -50.4 | -6,747.9 |
| Dividends Paid | 0 | -7,836.3 |
| Financing Cash Flow | 0 | -3,516.0 |
| Net Change in Cash | -31.8 | 1,146.1 |
| Ending Cash Balance | 13.2 | 2,665.2 |
| Interest Paid | — | -227.9 |
| Proceeds From Borrowings | — | 10,427 |
| Repayment Of Borrowings | — | -6,233.1 |